UK pharma major AstraZeneca on Friday revealed that Datroway (datopotamab deruxtecan or Dato-DXd) has been approved in the ...

US biotech Sage Therapeutics on Friday sued Biogen, a week after the biotech giant made an unsolicited offer to acquire the smaller neuroscience company for about $469 million, according to a ...

Telix Pharmaceuticals (TLX: ASX) has announced a definitive agreement to acquire key assets from ImaginAb, a specialist in ...

The US Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), has ...

Danish diabetes and obesity giant Novo Nordisk today announced headline results from STEP UP, a Phase IIIb trial in the ...

Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of medicines containing semaglutide following ...

The US Food and Drug Administration approved sotorasib (trade name Lumakras) with panitumumab Vectibix), from US biotech ...

The FDA grants AstraZeneca’s Calquence full approval for first-line mantle cell lymphoma as a combination therapy and ...

The WHO releases draft guidelines on implementing continuous manufacturing in pharmaceuticals, highlighting benefits like ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

German family-owned pharma major Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical ...

China's National Medical Products Administration (NMPA) has approved the New Drug Application (NDA) of limertinib for the ...